$4.4M investment headed to A2 pharmamceutical company
Ann Arbor-based Meditrina Pharmaceuticals Inc. was awarded $4.4 million in start-up funds that will allow the company to proceed with a Phase 2 clinical trial for a drug that might be used to treat several women’s health issues.
Ann Arbor-based Meditrina Pharmaceuticals Inc. was awarded $4.4 million in start-up funds that will allow the company to proceed with a Phase 2 clinical trial for a drug that might be used to treat several women’s health issues.
Excerpt:
Meditrina is currently enrolling women in a United States-based, multi-center, placebo-controlled study that will evaluate the appropriate time during the menstrual cycle in which to initiate dosing in premenopausal women to either induce or maintain a thin endometrium. The issue of timing during the menstrual cycle is crucial in order to progress into a subsequent phase II dose ranging trial (M002), as well as a larger pivotal phase III trial (M003), the latter of which is scheduled to commence in early 2008.
Related Articles
Partner Partner Content Suicide Prevention Month: Creating Connection Before a Crisis
Suicide prevention starts long before a crisis occurs. It begins by creating communities where people know they matter and know where they can turn when they need support.
Partner Partner Content Seeking mental health services can be overwhelming. Here’s where to begin
For people experiencing a mental health or substance use crisis, deciding where to turn for help can be overwhelming. Macomb County Community Mental Health offers a range of services designed to help residents navigate those decisions.
Rx Kids expansion to 60 Michigan communities is balancing family budgets and birthing healthier babies
The Michigan program is the largest unconditional cash transfer program for expectant parents in the country.
